summit trial tirzepatide JACC - #ACC25: A recent #JACC publication on the evaluates in patients with #HFpEF, with secondary analyses focusing on (1) cardiac structure and (2) #CKD. https://bit.ly/3EdDCQK 🧬 New data from the

Experimental investigations have reported modulation of intracellular cyclic AMP levels, alterations in gene expression related to metabolic signaling pathways, and changes in cellular metabolic activity in responsive tissues

Hypertension 75 , 894901 (2020)

When both receptors are activated simultaneously, the appetite-suppressing and metabolic effects appear to be additive in ways that single-receptor activation doesn't fully replicate

The flip side is a trap worth naming: some men take the fast start as license to push the dose up aggressively or to coast on the medication without changing anything else

Were redneck enough to be fat, but smart enough to do something about it, retired schoolteacher and Bowling Green resident Mary Sansom told Bloomberg.

Neurology is an area where thats definitely being driven by first, Alzheimers drugs getting approved, and then a more increased focus on some pipeline programslike BIIB080, the tau program Biogen has with Ionis [Pharmaceuticals]